Faculty of Biology, Medicine and Health

The University of Manchester

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities

  (UoM-Melb) Investigating inflammatory and neuronal mechanisms driving cognitive dysfunction in mild traumatic brain injury (concussion)

  Dr M Harte, Prof Stuart Allan, Dr Andrew Greenhalgh  No more applications being accepted  Competition Funded PhD Project (UK Students Only)

About the Project

Concussion, or mild traumatic brain injury (mTBI) affects millions world-wide each year due to motor accidents, falls, assaults, domestic violence, contact sports and war. It is now appreciated that a history of concussion increases the risk of developing long-term emotional and neurocognitive disorders. These include anxiety and depression, as well as neurodegenerative conditions such as Alzheimer’s. Critically, we do not know the mechanisms behind long-term negative effects of mTBI on brain health.

Over the last decade there is a growing literature emerging on how glial cells (microglia and astrocytes) and neuronal populations interact to control normal function and to understand how neuroinflammatory changes may be involved in the progression of a range of neuropsy chiatric and neurodegenerative disorders, a number of which are characterised by cognitive deficits.

In normal brain cognition is highly dependent on a balance between excitation (firing of pyramidal glutamatergic neurons) and inhibition (synchronisation of firing by parvalbumin containing GABAergic interneurons (PVI)). Gamma band oscillations, generated by these PVIs are crucial for maintenance of normal cognition. These interneurons are fast spiking, fast firing, have a high energy demand and as such are particularly susceptible to changes in neuroinflammation and oxidative stress. These interactions in different brains regions of relevance to cognition (e.g. prefrontal cortex & dorsal hippocampus) are now under intense scrutiny as changes in inflammation appear to be key drivers of brain injury, mood disorders and neurodegenerative disease. Understanding these interactions and their relationship over time in validated preclinical models related to TBI will aid in the identification and testing of novel therapeutic (both pharmacological and non-pharmacological (e.g. exercise)) interventions.

In the current project, we will investigate the immune cell response to mTBI in a clinically relevant mouse model. Our overall aims are to:

  • Assess the influence mTBI on brain resident immune cells (microglia/astrocyte density and activation), brain tissue inflammation (multiplex cytokine array analysis) and neuronal populations (parvalbumin GABAergic interneurons and associated perineuronal nets)
  • Utilise transgenic models and cell-depletion strategies in the mild TBI model. (Complimentary studies will be conducted in the moderate TBI model in Melbourne).
  • Target immune and neuronal cell subtypes and functions in the brain to prevent / reverse neuronal and behavioural deficits in mice after mTBI.

Supervisory Team:

Prof Michael HarteProf Stuart AllanDr Andrew Greenhalgh (The University of Manchester)

Dr Juliet TaylorProf Peter Crack (The University of Melbourne)

This project will be based at The University of Manchester, with at least 12 months spent at the University of Melbourne.

Entry Requirements

Candidates will need to meet the minimum entry requirements of both Universities to be accepted. You'll also need to be registered at both institutions for the duration of the programme. The entry criteria for the University of Melbourne can be found on their how to apply webpage. Candidates are expected to hold (or be about to obtain) a minimum upper second class honours degree (or equivalent) in a related area/subject to meet the entry criteria for the University of Manchester.

How to Apply

For further information about applying for one of the Manchester based projects can be found on our how to apply page. Candidates looking to apply for a Manchester-based project are encouraged to contact the named Manchester supervisor for an initial discussion before submitting an official application form. You MUST also submit an online application form - choose PhD Cancer Sciences.

Equality, diversity and inclusion is fundamental to the success of The University of Manchester, and is at the heart of all of our activities. The full Equality, diversity and inclusion statement can be found on the website https://www.bmh.manchester.ac.uk/study/research/apply/equality-diversity-inclusion/

Biological Sciences (4) Medicine (26)

Funding Notes

This is a Dual Award studentship between the University of Manchester and the University of Melbourne. Funding for the programme is for 3.5 years commencing on 1 September 2023 and will include tuition fees, an annual stipend at the minimum Research Councils UK rate (TBC for 2023/24), a research training grant and student travel to Melbourne.

Where will I study?

Faculty of Biology, Medicine and Health

Tackle real world challenges, make a difference, and elevate your career with postgraduate research in the Faculty of Biology, Medicine and Health at Manchester. From biochemistry to neuroscience, cancer sciences to medicine, audiology to mental health and everything in between, we offer a wide range of postgraduate research projects, programmes and funding which will allow you to immerse yourself in an area of research you’re passionate about.

Why study at Faculty of Biology, Medicine and Health?

Ranked the best place to live in the UK (The Economist Global Liveability Index, 2022), Manchester boasts world-class culture, iconic sports, a thriving music and food scene, and much more. It’s not just a place to research, it’s a place to call home.

Experience PhD life as part of a diverse postgraduate research community of more than 1,000 postgraduate researchers at the 29th most international university in the world (Times Higher Education, 2023).

With 93% of research activity at the University rated as ‘world-leading’ or ‘internationally excellent’ (Research Impact Framework, 2021), you’ll get the chance to have an impact on global health and science challenges.

1000+

postgraduate students

97

PhDs

6

ranked in UK - QS (2025)

Manchester  United Kingdom

main campus

Upcoming Open Days & Webinars

16

Sep 2024

The University of Manchester

Postgraduate Research Webinars - Biology, Medicine and Health

 Manchester

25

Sep 2024

The University of Manchester

Postgraduate Research Open Day - Biology, Medicine and Health

 Manchester


About Faculty of Biology, Medicine and Health

At Manchester, postgraduate researchers are at the heart of our mission to tackle pressing global challenges in biological, medical and healthcare sciences - and you could be too.

By choosing Manchester for your postgraduate research, you’ll be joining a university with an exceptional research reputation, where 93% of research is world-leading or internationally excellent (REF, 2021) and where your work will have real-world impact.

You’ll research in world-class facilities alongside leading experts at the forefront of innovation, collaborating across disciplines to pioneer new treatments, advance scientific knowledge, and improve healthcare globally.

Supported by our dedicated Doctoral Academy and strong industry links, you'll experience PhD life in a vibrant, welcoming and diverse postgraduate research community.

And you’ll leave with the specialist knowledge, research experience and transferable skills that will shape your future in academia, research or industry.


Main campus

The University of Manchester

Manchester

North West

United Kingdom

PhD saved sucessfully

A novel role in mitochondrial homeostasis for the anti-ageing factor RBBP5

The mitochondrion has evolved from the endosymbiotic interaction of an alpha-proteobacterium and an archaeon. One major event during this evolution was the transferring of genes from the symbiont to the host. Read more
More details

Bioinspired Nanomaterials Based Miniaturised Soft Robots for High Precision Regiospecific Drug Delivery to Malignant Tumours

Cancer is one of the top global public health challenges, estimated to have caused 10M deaths (2020) according to WHO. Throughout the years, standardised therapeutic protocols have been developed and evolved for the treatment of various types of cancers. Read more
More details

Cell-matrix interface engineering for regenerative medicine applications and disease modelling

Dr. Mahetab Amer is seeking motivated students with backgrounds in tissue engineering, cell biology, materials science, or related fields to join her dynamic, multidisciplinary research group at the Division of Cell Matrix Biology and Regenerative Medicine, University of Manchester. Read more
More details

Chaperones and the response to protein misfolding stress

Misfolded proteins are usually refolded to their functional conformations or degraded by quality control mechanisms. When misfolded proteins evade quality control, they form aggregates that are sequestered to specific sites within cells. Read more
More details

Circadian clock control of adipocyte metabolism

Obesity is a major public health issue affecting one third of UK adults, and an estimated 2.1 billion individuals worldwide. The role of circadian clock dysfunction in the development of obesity is becoming clear, with disruptive lifestyles (e.g. Read more
More details

Clinical Prediction Modelling under Federated Learning

Clinical prediction models (CPMs) take a set of characteristics about a patient to estimate their risk of an event of interest. Developing CPMs using data that captures observations across multiple clusters (e.g., countries) can increase the robustness and generalisability of CPMs. Read more
More details

Decoding the epigenetic mechanisms of drug resistance in aggressive breast cancers

Breast cancers pose a major health burden to modern world as being the most common cancer in women. Estrogen receptor (ER), the classical marker of 70% these cancers, is the nuclear receptor important for cancer progression. Read more
More details

Defining the molecular mechanisms of leukaemia chemotherapies

Chemotherapies are usually the backbone of cancer treatment for either curative or palliative patient care. Multiple therapies can be used for the same disease, with the choice of drug dependent on parameters such as the patient’s age and fitness. Read more
More details

Defining the role of glycation in extracellular matrix damage in ageing and diabetic skin

In skin, long-lived extracellular matrix (ECM) components in the dermis undergo a form of ageing where damage is accumulated to their protein structures by mechanisms such as glycation, photo-oxidation and protease cleavage, leading to profound changes in tissue architecture and function. Read more
More details

Delineating the IRF6 regulatory network driving periderm formation and function

During development, the ectoderm passes through a series of cell states to produce a self-replenishing, multi-layered epidermis. Initial stratification forms a single-cell layer of flattened periderm cells which act as a barrier to prevent pathological adhesions during embryogenesis. Read more
More details

Diagnostics for FMF patients and carrier survival in pandemics

Background. Familial Mediterranean Fever (FMF) is a rare inherited genetic disease where patients acquire a mutation on the pyrin gene leading to excessive inflammasome activation and excessive inflammation. Read more
More details

Driving phenotypic plasticity and metastasis in small cell lung cancer

Small cell lung cancer (SCLC) is an aggressive malignancy with poor prognosis. Underlying this aggressiveness is intra-tumoural heterogeneity driven by phenotypic plasticity wherein tumour cells transition from a neuroendocrine (NE) to a non-neuroendocrine (non-NE) phenotype. Read more
More details

Dysfunctional antifungal potency of the respiratory mucosa in COPD

Inhalation of Aspergillus fumigatus spores cause >3,000,000 chronic and >200,000 invasive diseases annually worldwide. Invasive aspergillosis carries a 50% mortality rate overall, but mortality rate approaches 100% if diagnosis is delayed or missed and it is >75% in certain cohorts of patients, such as COPD sufferers. Read more
More details

Early life factors in the development of Juvenile idiopathic arthritis

Juvenile idiopathic arthritis (JIA) is an autoimmune inflammatory arthritis with disease onset before the age of 16. Children and young people with this condition develop painful swollen joints and untreated it can lead to long term disability. It may also be associated with comorbid conditions such as uveitis. Read more
More details

Identification and structural analysis of transient interactions in supra-molecular complexes involved in protein synthesis

The aim of this project is to understand the dynamic interactions in the mechanism and control of protein synthesis in eukaryotic cells at the molecular level using hydrogen-deuterium exchange mass spectrometry (HDX-MS), and particularly the role of the eukaryotic translation initiation factors eIF2, eIF5 and eIF2B[1,2]. Read more
More details

Inducing ferroptotic death to kill cancer cells

Ferroptosis is an iron-dependent form of regulated necrotic cell death triggered by oxidative degradation of lipids in membrane bilayers and subsequent irreparable damages to the plasma membrane (1). Read more
More details

Intrinsic mechanisms of axonal regeneration following peripheral nerve injury

Peripheral nerve injury (PNI) is a common consequence of trauma with life-changing implications both physically (loss of limb function) and psychologically (impact on employment, personal relationships and wider wellbeing). Read more
More details

Investigating monogenic disorders of the protein synthesis machinery

Translation of mRNA into proteins is a critical cellular biological process. We recently described a novel human disorder, now called Faundes-Banka Syndrome (FABAS), caused by heterozygous variants in EIF5A1 that encodes a translation factor. Read more
More details

Investigating the cardio-pulmonary impact of airborne nanoplastics

There is growing evidence that humans are exposed to incidental microplastics and nanoplastics (MNPL) particles through inhalation and that the small size of these particles may allow for bioaccumulation and retention in the body. Read more
More details

Mechanistic analysis of neurodevelopmental disorders caused by mutations in the gene RAC1

RAC1 is a signalling protein that regulates many cellular processes and is essential during embryonic development. We recently discovered a novel genetic disease called RAC1-related neurodevelopmental disorder (RAC1-NDD) that results from mutations in the RAC1 gene. Read more
More details

Modelling the ecology and evolution of microbial communities

From the human gut to deep-sea sediments, microbial communities – or microbiomes – colonize virtually every habitat on earth. These microbiomes are central to ecosystem functioning and to host health, and therefore it is essential that we understand how and why they change over time. Read more
More details

Peptide-mediated nanocarrier drug delivery for enhanced brain targeting and treatment of inflammation

This project involves the study of nanoparticles and drug delivery to the brain. The student would be required to make and characterise novel nanoparticles from special lipid molecules of various compositions more suitable for blood-brain barrier (BBB) targeting. Read more
More details

PhD Nurses’ experiences of the usability of Electronic Health Records

The implementation of Electronic Health Records (EHRs) is rapidly increasing in both the UK and Australia. Nurses are the largest professional group working in the health and care sector, and are the main users of EHRs and other digital (and paper) documentation systems. Read more
More details

Sunlight exposure and cutaneous production of vitamin D in Black African/Afro-Caribbean adults

Our main source of vitamin D is through skin exposure to ultraviolet radiation (UVR) in sunlight. Vitamin D is essential for healthy bones and is associated with reduced incidence of several cancers and immune-mediated disorders. Read more
More details

The cellular response to stress: roles in disease and ageing

All living organisms need to adapt to their environment in order to survive and reproduce. They must respond to many stresses including altered oxygen levels, heat or cold, irradiation, infection and injury. Read more
More details

The circadian clock as a regulator of information processing

Endogenous biological clocks are a ubiquitous feature of living organisms, driving rhythms in countless cellular and physiological functions, and influencing almost all biological processes. Read more
More details

The epigenomic, transcriptional and diagnostic architecture of neurodevelopmental disorders caused by exposure to maternal infection

A fundamental unknown in understanding mechanisms of disease, and therefore improving therapy, is how stressors experienced during critical developmental periods influence the genesis or ‘programming’ of adult disease (Estes & McAllister 2016). Read more
More details

The impact of nutritional scavenging on host-pathogen interactions, antifungal efficacy and emergence of antifungal resistance

Infections caused by Aspergillus fumigatus (Af) cause more deaths globally than any other fungal disease. Over 20 million are affected annually with four million having life threatening invasive and chronic infections with high morbidity and mortality up to 90%. Read more